Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...
 
 

23rd Annual Diabetes Fall Symposium for Primary Health Care Professionals


- 23rd Annual -
Diabetes Fall Symposium for Primary Health Care Professionals
September 15, 2018
MUSC Drug Discovery Auditorium, 97 Jonathan Lucas Street, Charleston, SC
 
To register online, click here!
To view the final brochure (and to register via mail), click here!
To visit the Diabetes Initiative of SC website, click here!
 
This comprehensive update is specifically designed for Primary Care Physicians, Podiatrists, Endocrinologists, Pharmacists, PharmDs, NPs, APRNs, PAs, RDs, and CDEs. The information to be presented is equally relevant to RNs, LPNs, and Social Workers.
 
Program Learning Objectives
At the conclusion of the program, participants should be able to:
• Recognize the correlation of sleep apnea with diabetes,
• Assess how diabetes affects men’s health,
• Describe how to use new insulin products,
• Discuss treatment options for prefiabetes
• Review the orthopaedic considerations for the patient with diabetes,
• Identify evidence-based guidelines for cardiovascular disease associated with diabetes,
• Examine evidence-based pharmacotherapy for the treatment of DM.
 
To view the schedule of individual sessions as well as their learning objectives, please scroll to the bottom of the page. 
Clicking on the blue bars will expand the session details!

Date: Sep 15, 2018 08:00 AM - 04:30 PM

CE Hours

7.00

CE Units

0.700

Activity Type

  • Knowledge

Target Audience(s)

  • Pharmacists

Accreditation(s)

Accreditation Council for Pharmacy Education
The University of South Carolina College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Co-Sponsor(s)

Diabetes Initiative of SC

Requirements for CE Credit

Participants must sign in upon arrival and have attendance verified. To claim credit for this activity, participants must complete the online program evaluation and must update their accounts to properly reflect their month/day of birth and correct NABP e-Profile ID.  To register with NABP or look up your NABP e-Profile ID, please click on the CPE Monitor logo below to be directed to their site. Credit that is claimed greater than 60 days from the date of the program will be automatically rejected by the CPE Monitor.  Claiming credit within 30 days of the live program will ensure that any issues with transmission to the CPE Monitor can be rectified in advance of the 60-day deadline.  If you would like a paper statement of credit, you may print an individual statement or a transcript from your NABP e-Profile.

 

 

 

 

At the completion of this activity, the participant will be able to:
  1. Recognize the correlation of sleep apnea with diabetes
  2. Discuss treatment options for sleep disorders
  3. Describe the relationship of insulin resistance to sleep disorders

Speaker(s)/Author(s)

Chitra Lal, MD
Associate Professor; Division of Pulmonary and Critical Care, Medical University of South Carolina

Activity Number

0062-9999-18-148-L01-P
Date: 09/15/18
Time: 08:00 AM - 09:00 AM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to:
  1. Analyze the implications of diabetes with men’s reproductive health
  2. Discuss treatment options for erectile dysfunction
  3. Review hypogonadism and testosterone replacement therapy

Speaker(s)/Author(s)

Marc J. Rogers, MD
Assistant Professor of Medicine; Department of Urology, Medical University of South Carolina

Activity Number

0062-9999-18-149-L01-P
Date: 09/15/18
Time: 09:00 AM - 10:00 AM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to:
  1. Describe how to use new insulin products
  2. Review the basics of Basal/Bolus insulin delivery
  3. Discuss the nature of basal insulins
  4. Assess the appropriate use of basal insulin in type 1 and type 2 diabetes

Speaker(s)/Author(s)

Donald C. Eagerton, MD
Endocrinologist; Carolina Health Specialists, Grand Strand Health

Activity Number

0062-9999-18-150-L01-P
Date: 09/15/18
Time: 10:15 AM - 11:15 AM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to:
  1. Discuss treatment options for prediabetes
  2. Review the body of literature for clinical trials aimed at diabetes prevention
  3. Discuss alternate outcomes had restoration of normoglycemia been the goal
  4. Extend the paradigm of diabetes prevention to the prevention of complications in people with pre-diabetes

Speaker(s)/Author(s)

Aundrea Loftley, MD
Endocrinologist, McLeod Endocrinology Associates

Activity Number

0062-9999-18-151-L01-P
Date: 09/15/18
Time: 11:15 AM - 12:15 AM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to:
  1. Review the orthopedic considerations for the patient with diabetes
  2. Describe warning signs/symptoms of foot problems
  3. Discuss recommendations for the prevention of orthopedic foot problems

Speaker(s)/Author(s)

Christopher E. Gross, MD
Orthopedic Surgeon; Department of Orthopedics, Medical University of South Carolina

Activity Number

0062-9999-18-152-L01-P
Date: 09/15/18
Time: 01:15 PM - 02:15 PM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to:
  1. Identify evidence-based guidelines for cardiovascular disease associated with diabetes
  2. Define cardiovascular risk and assess the non-modifiable and modifiable risk factors
  3. Describe the benefits of early interventions

Speaker(s)/Author(s)

Valerian Fernandes, MD, MRCP, FACC
Professor of Medicine; Division of Cardiology, Medical University of South Carolina

Activity Number

0062-9999-18-153-L01-P
Date: 09/15/18
Time: 02:15 PM - 03:15 PM

CE Hours

1.00
 

 

At the completion of this activity, the participant will be able to:
  1. Examine evidence-based pharmacotherapy for treatment of diabetes
  2. Review and compare the new AACE Treatment Guidelines with the ADA-EASD patient-focused guidelines for pharmacologic management of Type 2 diabetes
  3. Identify strategies for assisting patients with barriers to receiving optimal and affordable medications (discount programs, patient assistance programs, coupons, etc.)
  4. Discuss recent warnings and label changes for currently available drug therapies for diabetes
  5. Discuss new products and dose formulations and their potential role in therapy including clinical effectiveness, adverse effects and drug interactions
  6. Review new clinical data that impact drug therapy options for treatment and prevention of comorbid conditions and complications associated with diabetes (hypertension, dyslipidemia, neuropathy)

Speaker(s)/Author(s)

C. Wayne Weart, PharmD, BCPS, FASHP, FAPhA
Professor of Clinical Pharmacology & Outcomes Science; Professor of Family Medicine, Medical University of South Carolina

Activity Number

0062-9999-18-154-L01-P
Date: 09/15/18
Time: 03:30 PM - 04:30 PM

CE Hours

1.00